Pendal Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,872
Closed -$357K 516
2021
Q4
$357K Buy
+6,872
New +$355K ﹤0.01% 458
2021
Q3
Sell
-5,029
Closed -$312K 592
2021
Q2
$312K Hold
5,029
﹤0.01% 491
2021
Q1
$328K Buy
5,029
+994
+25% +$64.8K ﹤0.01% 467
2020
Q4
$265K Sell
4,035
-859
-18% -$50.5K ﹤0.01% 461
2020
Q3
$253K Buy
+4,894
New +$251K ﹤0.01% 381

Other funds holding EHC

Pendal Group's EHC Position: Q1 2022 in Review

Pendal Group sold out of Encompass Health (EHC) in Q1 2022, closing a stake of 6,872 shares — an estimated $357K sold.

Pendal Group first reported a position in EHC in Q3 2020 and held it in 5 quarters. The position peaked at $357K in Q4 2021. 406 funds tracked by Wall St. Rank hold EHC as of Q1 2022.

  • Pendal Group reported no remaining Encompass Health position as of Q1 2022 after selling out during the quarter.
  • Pendal Group sold 6,872 Encompass Health shares in Q1 2022, an estimated $357K.
  • Pendal Group first reported a position in Encompass Health in Q3 2020 and held it in 5 quarters.
  • Pendal Group's Encompass Health position peaked at $357K in Q4 2021.
  • 406 funds tracked by Wall St. Rank held Encompass Health as of Q1 2022.

Based on Pendal Group's 13F filing for Q1 2022, filed 25 Apr 2022.